{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:06:49Z","timestamp":1791223609613,"version":"4.1.0"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100013360","name":"Universidade Do Extremo Sul Catarinense","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013360","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics & Antimicro. Prot."],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s12602-026-10927-w","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T07:35:11Z","timestamp":1772609711000},"page":"8209-8225","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Exploring the Gut-Brain Connection: Are Probiotics the Next Frontier in Alzheimer\u2019s Disease Treatment?"],"prefix":"10.1007","volume":"18","author":[{"given":"Eduarda Behenck","family":"Medeiros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrielly Vargas","family":"Lidio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel Casagrande","family":"Zabot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela Piovesan","family":"Fenilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"de Bem Silveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela Serafim","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1vio Rigoberto Arriagata","family":"Carrion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Guarino","family":"De Felice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Kluwe-Schiavon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consuelo","family":"Walls-Bass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Barichello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4241-2743","authenticated-orcid":false,"given":"Josiane","family":"Budni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"10927_CR1","unstructured":"ALZHEIMER\u2019S ASSOCIATION (2024) Alzheimer\u2019s disease facts and figures"},{"key":"10927_CR2","doi-asserted-by":"publisher","unstructured":"Bernier V, Chatelan A, Point C, et al (2025) Nutrition and neuroinflammation: are middle-aged women in the red zone? Nutrients 17:1607. https:\/\/doi.org\/10.3390\/nu17101607","DOI":"10.3390\/nu17101607"},{"key":"10927_CR3","doi-asserted-by":"publisher","unstructured":"Tiwari S, Atluri V, Kaushik A, et al (2019) Alzheimer\u2019s disease: pathogenesis, diagnostics, and therapeutics. Int J Nanomedicine 14:5541\u20135554. https:\/\/doi.org\/10.2147\/IJN.S200490","DOI":"10.2147\/IJN.S200490"},{"key":"10927_CR4","doi-asserted-by":"publisher","unstructured":"Therriault J, Zimmer ER, Benedet AL, et al (2022) Staging of Alzheimer\u2019s disease: past, present, and future perspectives. Trends Mol Med 28:726\u2013741. https:\/\/doi.org\/10.1016\/j.molmed.2022.05.008","DOI":"10.1016\/j.molmed.2022.05.008"},{"key":"10927_CR5","doi-asserted-by":"publisher","unstructured":"Prajapati SK, Pathak A, Samaiya PK (2024) Alzheimer\u2019s disease: from early pathogenesis to novel therapeutic approaches. Metab Brain Dis 39:1231\u20131254. https:\/\/doi.org\/10.1007\/s11011-024-01389-6","DOI":"10.1007\/s11011-024-01389-6"},{"key":"10927_CR6","doi-asserted-by":"publisher","unstructured":"Raket LL, Pichet Binette A, Mattsson-Carlgren N, et al (2025) Estimating the time course of biomarker changes in Alzheimer\u2019s disease. Brain. https:\/\/doi.org\/10.1093\/brain\/awaf413","DOI":"10.1093\/brain\/awaf413"},{"key":"10927_CR7","doi-asserted-by":"publisher","unstructured":"Rathee S, Sen D, Pandey V, Jain SK (2024) Advances in understanding and managing Alzheimer\u2019s disease: from pathophysiology to innovative therapeutic strategies. Curr Drug Targets 25:752\u2013774. https:\/\/doi.org\/10.2174\/0113894501320096240627071400","DOI":"10.2174\/0113894501320096240627071400"},{"key":"10927_CR8","doi-asserted-by":"publisher","unstructured":"Mil\u00e0-Alom\u00e0 M, Tosun D, Schindler SE, et al (2025) Timing of changes in Alzheimer\u2019s disease plasma biomarkers as assessed by amyloid and tau PET clocks. Ann Neurol 98:508\u2013523. https:\/\/doi.org\/10.1002\/ana.27285","DOI":"10.1002\/ana.27285"},{"key":"10927_CR9","doi-asserted-by":"publisher","unstructured":"Wegmann S, Biernat J, Mandelkow E (2021) A current view on tau protein phosphorylation in Alzheimer\u2019s disease. Curr Opin Neurobiol 69:131\u2013138. https:\/\/doi.org\/10.1016\/j.conb.2021.03.003","DOI":"10.1016\/j.conb.2021.03.003"},{"key":"10927_CR10","doi-asserted-by":"publisher","unstructured":"Naomi R, Embong H, Othman F, et al (2021) Probiotics for Alzheimer\u2019s disease: a systematic review. Nutrients 14:20. https:\/\/doi.org\/10.3390\/nu14010020","DOI":"10.3390\/nu14010020"},{"key":"10927_CR11","doi-asserted-by":"publisher","unstructured":"Simpson CA, Diaz-Arteche C, Eliby D, et al (2021) The gut microbiota in anxiety and depression \u2013 a systematic review. Clin Psychol Rev 83:101943. https:\/\/doi.org\/10.1016\/j.cpr.2020.101943","DOI":"10.1016\/j.cpr.2020.101943"},{"key":"10927_CR12","doi-asserted-by":"publisher","unstructured":"DiSabato DJ, Quan N, Godbout JP (2016) Neuroinflammation: the devil is in the details. J Neurochem 139:136\u2013153. https:\/\/doi.org\/10.1111\/jnc.13607","DOI":"10.1111\/jnc.13607"},{"key":"10927_CR13","doi-asserted-by":"publisher","unstructured":"Leng F, Edison P (2021) Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol 17:157\u2013172. https:\/\/doi.org\/10.1038\/s41582-020-00435-y","DOI":"10.1038\/s41582-020-00435-y"},{"key":"10927_CR14","doi-asserted-by":"publisher","unstructured":"Chitnis T, Weiner HL (2017) CNS inflammation and neurodegeneration. J Clin Invest 127:3577\u20133587. https:\/\/doi.org\/10.1172\/JCI90609","DOI":"10.1172\/JCI90609"},{"key":"10927_CR15","doi-asserted-by":"publisher","unstructured":"Ferreira ST, Clarke JR, Bomfim TR, De Felice FG (2014) Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer\u2019s disease. Alzheimers Dement 10. https:\/\/doi.org\/10.1016\/j.jalz.2013.12.010","DOI":"10.1016\/j.jalz.2013.12.010"},{"key":"10927_CR16","doi-asserted-by":"publisher","unstructured":"S\u00e1nchez-Saras\u00faa S, Fern\u00e1ndez-P\u00e9rez I, Espinosa-Fern\u00e1ndez V, et al (2020) Can we treat neuroinflammation in Alzheimer\u2019s disease? Int J Mol Sci 21:8751. https:\/\/doi.org\/10.3390\/ijms21228751","DOI":"10.3390\/ijms21228751"},{"key":"10927_CR17","doi-asserted-by":"publisher","unstructured":"Doens D, Fern\u00e1ndez PL (2014) Microglia receptors and their implications in the response to amyloid \u03b2 for Alzheimer\u2019s disease pathogenesis. J Neuroinflammation 11:48. https:\/\/doi.org\/10.1186\/1742-2094-11-48","DOI":"10.1186\/1742-2094-11-48"},{"key":"10927_CR18","doi-asserted-by":"publisher","unstructured":"Kitazawa M, Cheng D, Tsukamoto MR, et al (2011) Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal \u03b2-catenin pathway function in an Alzheimer\u2019s disease model. J Immunol 187:6539\u20136549. https:\/\/doi.org\/10.4049\/jimmunol.1100620","DOI":"10.4049\/jimmunol.1100620"},{"key":"10927_CR19","doi-asserted-by":"publisher","unstructured":"Yang W, Liu Y, Xu Q-Q, et al (2020) Sulforaphene ameliorates neuroinflammation and hyperphosphorylated tau protein via regulating the PI3K\/Akt\/GSK-3 \u03b2 pathway in experimental models of Alzheimer\u2019s disease. Oxid Med Cell Longev 2020:1\u201317. https:\/\/doi.org\/10.1155\/2020\/4754195","DOI":"10.1155\/2020\/4754195"},{"key":"10927_CR20","doi-asserted-by":"publisher","unstructured":"Ren S, Yao W, Tambini MD, et al (2020) Microglia TREM2R47H Alzheimer-linked variant enhances excitatory transmission and reduces LTP via increased TNF-\u03b1 levels. Elife 9. https:\/\/doi.org\/10.7554\/eLife.57513","DOI":"10.7554\/eLife.57513"},{"key":"10927_CR21","doi-asserted-by":"publisher","unstructured":"Contreras JA, Aslanyan V, Albrecht DS, et al (2022) Higher baseline levels of CSF inflammation increase risk of incident mild cognitive impairment and Alzheimer\u2019s disease dementia. Alzheimers Dement 14. https:\/\/doi.org\/10.1002\/dad2.12346","DOI":"10.1002\/dad2.12346"},{"key":"10927_CR22","doi-asserted-by":"publisher","unstructured":"Heneka MT, Gauthier S, Chandekar SA, et al (2025) Neuroinflammatory fluid biomarkers in patients with Alzheimer\u2019s disease: a systematic literature review. Mol Psychiatry 30:2783\u20132798. https:\/\/doi.org\/10.1038\/s41380-025-02939-9","DOI":"10.1038\/s41380-025-02939-9"},{"key":"10927_CR23","doi-asserted-by":"publisher","unstructured":"Yang J, Ran M, Li H, et al (2022) New insight into neurological degeneration: inflammatory cytokines and blood\u2013brain barrier. Front Mol Neurosci 15. https:\/\/doi.org\/10.3389\/fnmol.2022.1013933","DOI":"10.3389\/fnmol.2022.1013933"},{"key":"10927_CR24","doi-asserted-by":"publisher","unstructured":"Bachstetter AD, Xing B, de Almeida L, et al (2011) Microglial p38\u03b1 MAPK is a key regulator of proinflammatory cytokine up-regulation induced by toll-like receptor (TLR) ligands or beta-amyloid (A\u03b2). J Neuroinflammation 8:79. https:\/\/doi.org\/10.1186\/1742-2094-8-79","DOI":"10.1186\/1742-2094-8-79"},{"key":"10927_CR25","doi-asserted-by":"publisher","unstructured":"He N, Jin W-L, Lok K-H, et al (2013) Amyloid-\u03b21\u201342 oligomer accelerates senescence in adult hippocampal neural stem\/progenitor cells via formylpeptide receptor 2. Cell Death Dis 4:e924. https:\/\/doi.org\/10.1038\/cddis.2013.437","DOI":"10.1038\/cddis.2013.437"},{"key":"10927_CR26","doi-asserted-by":"publisher","unstructured":"Stuart T, Butler A, Hoffman P, et al (2019) Comprehensive integration of single-cell data. Cell 177:1888-1902.e21. https:\/\/doi.org\/10.1016\/j.cell.2019.05.031","DOI":"10.1016\/j.cell.2019.05.031"},{"key":"10927_CR27","doi-asserted-by":"publisher","unstructured":"Chen J, Li J, Jiang H, et al (2021) Developmental co-exposure of TBBPA and titanium dioxide nanoparticle induced behavioral deficits in larval zebrafish. Ecotoxicol Environ Saf 215:112176. https:\/\/doi.org\/10.1016\/j.ecoenv.2021.112176","DOI":"10.1016\/j.ecoenv.2021.112176"},{"key":"10927_CR28","doi-asserted-by":"publisher","unstructured":"Heckmann BL, Teubner BJW, Tummers B, et al (2019) LC3-associated endocytosis facilitates \u03b2-amyloid clearance and mitigates neurodegeneration in murine Alzheimer\u2019s disease. Cell 178:536-551.e14. https:\/\/doi.org\/10.1016\/j.cell.2019.05.056","DOI":"10.1016\/j.cell.2019.05.056"},{"key":"10927_CR29","doi-asserted-by":"publisher","unstructured":"Long JM, Holtzman DM (2019) Alzheimer disease: an update on pathobiology and treatment strategies. Cell 179:312\u2013339. https:\/\/doi.org\/10.1016\/j.cell.2019.09.001","DOI":"10.1016\/j.cell.2019.09.001"},{"key":"10927_CR30","doi-asserted-by":"publisher","unstructured":"Paolicelli RC, Sierra A, Stevens B, et al (2022) Microglia states and nomenclature: a field at its crossroads. Neuron 110:3458\u20133483. https:\/\/doi.org\/10.1016\/j.neuron.2022.10.020","DOI":"10.1016\/j.neuron.2022.10.020"},{"key":"10927_CR31","doi-asserted-by":"publisher","unstructured":"Parhizkar S, Arzberger T, Brendel M, et al (2019) Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE. Nat Neurosci 22:191\u2013204. https:\/\/doi.org\/10.1038\/s41593-018-0296-9","DOI":"10.1038\/s41593-018-0296-9"},{"key":"10927_CR32","doi-asserted-by":"publisher","unstructured":"Fruhw\u00fcrth S, Zetterberg H, Paludan SR (2024) Microglia and amyloid plaque formation in Alzheimer\u2019s disease \u2013 evidence, possible mechanisms, and future challenges. J Neuroimmunol 390:578342. https:\/\/doi.org\/10.1016\/j.jneuroim.2024.578342","DOI":"10.1016\/j.jneuroim.2024.578342"},{"key":"10927_CR33","doi-asserted-by":"publisher","unstructured":"de Oliveira J, Kucharska E, Garcez ML, et al (2021) Inflammatory cascade in Alzheimer\u2019s disease pathogenesis: a review of experimental findings. Cells 10:2581. https:\/\/doi.org\/10.3390\/cells10102581","DOI":"10.3390\/cells10102581"},{"key":"10927_CR34","doi-asserted-by":"publisher","unstructured":"Heneka MT (2017) Inflammasome activation and innate immunity in Alzheimer\u2019s disease. Brain Pathol 27:220\u2013222. https:\/\/doi.org\/10.1111\/bpa.12483","DOI":"10.1111\/bpa.12483"},{"key":"10927_CR35","doi-asserted-by":"publisher","unstructured":"Liu Y, Dai Y, Li Q, et al (2020) Beta-amyloid activates NLRP3 inflammasome via TLR4 in mouse microglia. Neurosci Lett 736:135279. https:\/\/doi.org\/10.1016\/j.neulet.2020.135279","DOI":"10.1016\/j.neulet.2020.135279"},{"key":"10927_CR36","doi-asserted-by":"publisher","unstructured":"Heneka MT, Kummer MP, Stutz A, et al (2013) NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature 493:674\u2013678. https:\/\/doi.org\/10.1038\/nature11729","DOI":"10.1038\/nature11729"},{"key":"10927_CR37","doi-asserted-by":"publisher","unstructured":"Stuart KE, King AE, King NE, et al (2019) Late-life environmental enrichment preserves short-term memory and may attenuate microglia in male APP\/PS1 mice. Neuroscience 408:282\u2013292. https:\/\/doi.org\/10.1016\/j.neuroscience.2019.04.015","DOI":"10.1016\/j.neuroscience.2019.04.015"},{"key":"10927_CR38","doi-asserted-by":"publisher","unstructured":"Kowalski K, Mulak A (2019) Brain-gut-microbiota axis in Alzheimer\u2019s disease. J Neurogastroenterol Motil 25:48\u201360. https:\/\/doi.org\/10.5056\/jnm18087","DOI":"10.5056\/jnm18087"},{"key":"10927_CR39","doi-asserted-by":"publisher","unstructured":"Lannes N, Eppler E, Etemad S, et al (2017) Microglia at center stage: a comprehensive review about the versatile and unique residential macrophages of the central nervous system. Oncotarget 8:114393\u2013114413. https:\/\/doi.org\/10.18632\/oncotarget.23106","DOI":"10.18632\/oncotarget.23106"},{"key":"10927_CR40","doi-asserted-by":"publisher","unstructured":"Sadigh-Eteghad S, Sabermarouf B, Majdi A, et al (2015) Amyloid-beta: a crucial factor in Alzheimer\u2019s disease. Med Princ Pract 24:1\u201310. https:\/\/doi.org\/10.1159\/000369101","DOI":"10.1159\/000369101"},{"key":"10927_CR41","doi-asserted-by":"publisher","unstructured":"Ghosh S, Wu MD, Shaftel SS, et al (2013) Sustained interleukin-1\u03b2 overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer\u2019s mouse model. J Neurosci 33:5053\u20135064. https:\/\/doi.org\/10.1523\/JNEUROSCI.4361-12.2013","DOI":"10.1523\/JNEUROSCI.4361-12.2013"},{"key":"10927_CR42","doi-asserted-by":"publisher","unstructured":"Koistinaho J, Malm T, Goldsteins G (2011) Glycogen synthase kinase-3 \u03b2: a mediator of inflammation in Alzheimer\u2019s disease? Int J Alzheimers Dis 2011. https:\/\/doi.org\/10.4061\/2011\/129753","DOI":"10.4061\/2011\/129753"},{"key":"10927_CR43","doi-asserted-by":"publisher","unstructured":"Gonz\u00e1lez Olmo BM, Butler MJ, Barrientos RM (2021) Evolution of the human diet and its impact on gut microbiota, immune responses, and brain health. Nutrients 13:196. https:\/\/doi.org\/10.3390\/nu13010196","DOI":"10.3390\/nu13010196"},{"key":"10927_CR44","doi-asserted-by":"publisher","unstructured":"Marano G, Mazza M, Lisci FM, et al (2023) The microbiota\u2013gut\u2013brain axis: psychoneuroimmunological insights. Nutrients 15:1496. https:\/\/doi.org\/10.3390\/nu15061496","DOI":"10.3390\/nu15061496"},{"key":"10927_CR45","doi-asserted-by":"publisher","unstructured":"Sender R, Fuchs S, Milo R (2016) Revised estimates for the number of human and bacteria cells in the body. PLoS Biol 14:e1002533. https:\/\/doi.org\/10.1371\/journal.pbio.1002533","DOI":"10.1371\/journal.pbio.1002533"},{"key":"10927_CR46","doi-asserted-by":"publisher","unstructured":"Gill SR, Pop M, DeBoy RT, et al (2006) Metagenomic analysis of the human distal gut microbiome. Science 312:1355\u20131359. https:\/\/doi.org\/10.1126\/science.1124234","DOI":"10.1126\/science.1124234"},{"key":"10927_CR47","doi-asserted-by":"publisher","unstructured":"Handley SA, Dube PH, Miller VL (2006) Histamine signaling through the H2 receptor in the Peyer\u2019s patch is important for controlling Yersinia enterocolitica infection. Proc Natl Acad Sci USA 103:9268\u20139273. https:\/\/doi.org\/10.1073\/pnas.0510414103","DOI":"10.1073\/pnas.0510414103"},{"key":"10927_CR48","doi-asserted-by":"publisher","unstructured":"Bonaz B, Bazin T, Pellissier S (2018) The vagus nerve at the interface of the microbiota-gut-brain axis. Front Neurosci 12. https:\/\/doi.org\/10.3389\/fnins.2018.00049","DOI":"10.3389\/fnins.2018.00049"},{"key":"10927_CR49","doi-asserted-by":"publisher","unstructured":"Westfall CS, Levin PA (2017) Bacterial cell size: multifactorial and multifaceted. Annu Rev Microbiol 71:499\u2013517. https:\/\/doi.org\/10.1146\/annurev-micro-090816-093803","DOI":"10.1146\/annurev-micro-090816-093803"},{"key":"10927_CR50","doi-asserted-by":"publisher","unstructured":"Sharon G, Sampson TR, Geschwind DH, Mazmanian SK (2016) The central nervous system and the gut microbiome. Cell 167:915\u2013932. https:\/\/doi.org\/10.1016\/j.cell.2016.10.027","DOI":"10.1016\/j.cell.2016.10.027"},{"key":"10927_CR51","doi-asserted-by":"publisher","unstructured":"Ma J, Hong Y, Zheng N, et al (2020) Gut microbiota remodeling reverses aging-associated inflammation and dysregulation of systemic bile acid homeostasis in mice sex-specifically. Gut Microbes 11:1450\u20131474. https:\/\/doi.org\/10.1080\/19490976.2020.1763770","DOI":"10.1080\/19490976.2020.1763770"},{"key":"10927_CR52","doi-asserted-by":"publisher","unstructured":"Santos-Marcos JA, Mora-Ortiz M, Tena-Sempere M, et al (2023) Interaction between gut microbiota and sex hormones and their relation to sexual dimorphism in metabolic diseases. Biol Sex Differ 14:4. https:\/\/doi.org\/10.1186\/s13293-023-00490-2","DOI":"10.1186\/s13293-023-00490-2"},{"key":"10927_CR53","doi-asserted-by":"publisher","unstructured":"Christ A, Lauterbach M, Latz E (2019) Western diet and the immune system: an inflammatory connection. Immunity 51:794\u2013811. https:\/\/doi.org\/10.1016\/j.immuni.2019.09.020","DOI":"10.1016\/j.immuni.2019.09.020"},{"key":"10927_CR54","doi-asserted-by":"publisher","unstructured":"Garc\u00eda-Montero C, Fraile-Mart\u00ednez O, G\u00f3mez-Lahoz AM, et al (2021) Nutritional components in Western diet versus Mediterranean diet at the gut microbiota\u2013immune system interplay. Nutrients 13:699. https:\/\/doi.org\/10.3390\/nu13020699","DOI":"10.3390\/nu13020699"},{"key":"10927_CR55","doi-asserted-by":"publisher","unstructured":"Hoscheidt S, Sanderlin AH, Baker LD, et al (2022) Mediterranean and Western diet effects on Alzheimer\u2019s disease biomarkers, cerebral perfusion, and cognition in mid-life: a randomized trial. Alzheimers Dement 18:457\u2013468. https:\/\/doi.org\/10.1002\/alz.12421","DOI":"10.1002\/alz.12421"},{"key":"10927_CR56","doi-asserted-by":"publisher","unstructured":"Rom\u00e1n GC, Jackson RE, Gadhia R, et al (2019) Mediterranean diet: the role of long-chain \u03c9-3 fatty acids in fish; polyphenols in fruits, vegetables, cereals, coffee, tea, cacao and wine; probiotics and vitamins in prevention of stroke, age-related cognitive decline, and Alzheimer disease. Rev Neurol (Paris) 175:724\u2013741. https:\/\/doi.org\/10.1016\/j.neurol.2019.08.005","DOI":"10.1016\/j.neurol.2019.08.005"},{"key":"10927_CR57","doi-asserted-by":"publisher","unstructured":"Wang F, Roy S (2017) Gut homeostasis, microbial dysbiosis, and opioids. Toxicol Pathol 45:150\u2013156. https:\/\/doi.org\/10.1177\/0192623316679898","DOI":"10.1177\/0192623316679898"},{"key":"10927_CR58","doi-asserted-by":"publisher","unstructured":"Kim KS, Suzuki K, Cho H, et al (2018) Oral nanoparticles exhibit specific high-efficiency intestinal uptake and lymphatic transport. ACS Nano 12:8893\u20138900. https:\/\/doi.org\/10.1021\/acsnano.8b04315","DOI":"10.1021\/acsnano.8b04315"},{"key":"10927_CR59","doi-asserted-by":"publisher","unstructured":"Snigdha S, Ha K, Tsai P, et al (2022) Probiotics: potential novel therapeutics for microbiota-gut-brain axis dysfunction across gender and lifespan. Pharmacol Ther 231:107978. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107978","DOI":"10.1016\/j.pharmthera.2021.107978"},{"key":"10927_CR60","doi-asserted-by":"publisher","unstructured":"Mayer EA, Knight R, Mazmanian SK, et al (2014) Gut microbes and the brain: paradigm shift in neuroscience. J Neurosci 34:15490\u201315496. https:\/\/doi.org\/10.1523\/JNEUROSCI.3299-14.2014","DOI":"10.1523\/JNEUROSCI.3299-14.2014"},{"key":"10927_CR61","doi-asserted-by":"publisher","unstructured":"Quigley EMM (2017) Microbiota-brain-gut axis and neurodegenerative diseases. Curr Neurol Neurosci Rep 17:94. https:\/\/doi.org\/10.1007\/s11910-017-0802-6","DOI":"10.1007\/s11910-017-0802-6"},{"key":"10927_CR62","doi-asserted-by":"publisher","unstructured":"Angelucci F, Cechova K, Amlerova J, Hort J (2019) Antibiotics, gut microbiota, and Alzheimer\u2019s disease. J Neuroinflammation 16:108. https:\/\/doi.org\/10.1186\/s12974-019-1494-4","DOI":"10.1186\/s12974-019-1494-4"},{"key":"10927_CR63","doi-asserted-by":"publisher","unstructured":"Megur A, Baltriukien\u0117 D, Bukelskien\u0117 V, Burokas A (2020) The microbiota\u2013gut\u2013brain axis and Alzheimer\u2019s disease: neuroinflammation is to blame? Nutrients 13:37. https:\/\/doi.org\/10.3390\/nu13010037","DOI":"10.3390\/nu13010037"},{"key":"10927_CR64","doi-asserted-by":"publisher","unstructured":"Claesson MJ, Jeffery IB, Conde S, et al (2012) Gut microbiota composition correlates with diet and health in the elderly. Nature 488:178\u2013184. https:\/\/doi.org\/10.1038\/nature11319","DOI":"10.1038\/nature11319"},{"key":"10927_CR65","doi-asserted-by":"publisher","unstructured":"Camilleri M (1990) Disorders of gastrointestinal motility in neurologic diseases. Mayo Clin Proc 65:825\u2013846. https:\/\/doi.org\/10.1016\/S0025-6196(12)62574-9","DOI":"10.1016\/S0025-6196(12)62574-9"},{"key":"10927_CR66","unstructured":"Catanzaro R, Anzalone M, Calabrese F, et al (2015) The gut microbiota and its correlations with the central nervous system disorders. Panminerva Med 57:127\u2013143"},{"key":"10927_CR67","doi-asserted-by":"publisher","unstructured":"Cryan JF, O\u2019Riordan KJ, Cowan CSM, et al (2019) The microbiota-gut-brain axis. Physiol Rev 99:1877\u20132013. https:\/\/doi.org\/10.1152\/physrev.00018.2018","DOI":"10.1152\/physrev.00018.2018"},{"key":"10927_CR68","doi-asserted-by":"publisher","unstructured":"Collins SM, Surette M, Bercik P (2012) The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol 10:735\u2013742. https:\/\/doi.org\/10.1038\/nrmicro2876","DOI":"10.1038\/nrmicro2876"},{"key":"10927_CR69","doi-asserted-by":"publisher","unstructured":"Carloni S, Rescigno M (2023) The gut-brain vascular axis in neuroinflammation. Semin Immunol 69:101802. https:\/\/doi.org\/10.1016\/j.smim.2023.101802","DOI":"10.1016\/j.smim.2023.101802"},{"key":"10927_CR70","doi-asserted-by":"publisher","unstructured":"Franceschi C, Garagnani P, Parini P, et al (2018) Inflammaging: a new immune\u2013metabolic viewpoint for age-related diseases. Nat Rev Endocrinol 14:576\u2013590. https:\/\/doi.org\/10.1038\/s41574-018-0059-4","DOI":"10.1038\/s41574-018-0059-4"},{"key":"10927_CR71","doi-asserted-by":"publisher","unstructured":"Han W, Tellez LA, Perkins MH, et al (2018) A neural circuit for gut-induced reward. Cell 175:887\u2013888. https:\/\/doi.org\/10.1016\/j.cell.2018.10.018","DOI":"10.1016\/j.cell.2018.10.018"},{"key":"10927_CR72","doi-asserted-by":"publisher","unstructured":"Wallrapp A, Chiu IM (2024) Neuroimmune interactions in the intestine. Annu Rev Immunol 42:489\u2013519. https:\/\/doi.org\/10.1146\/annurev-immunol-101921-042929","DOI":"10.1146\/annurev-immunol-101921-042929"},{"key":"10927_CR73","doi-asserted-by":"publisher","unstructured":"Doifode T, Giridharan VV, Generoso JS, et al (2021) The impact of the microbiota-gut-brain axis on Alzheimer\u2019s disease pathophysiology. Pharmacol Res 164:105314. https:\/\/doi.org\/10.1016\/j.phrs.2020.105314","DOI":"10.1016\/j.phrs.2020.105314"},{"key":"10927_CR74","doi-asserted-by":"publisher","unstructured":"Seo D, Boros BD, Holtzman DM (2019) The microbiome: a target for Alzheimer disease? Cell Res 29:779\u2013780. https:\/\/doi.org\/10.1038\/s41422-019-0227-7","DOI":"10.1038\/s41422-019-0227-7"},{"key":"10927_CR75","doi-asserted-by":"publisher","unstructured":"Cattaneo A, Cattane N, Galluzzi S, et al (2017) Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging 49:60\u201368. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.08.019","DOI":"10.1016\/j.neurobiolaging.2016.08.019"},{"key":"10927_CR76","doi-asserted-by":"publisher","unstructured":"Verhaar BJH, Hendriksen HMA, de Leeuw FA, et al (2022) Gut microbiota composition is related to AD pathology. Front Immunol 12. https:\/\/doi.org\/10.3389\/fimmu.2021.794519","DOI":"10.3389\/fimmu.2021.794519"},{"key":"10927_CR77","doi-asserted-by":"publisher","unstructured":"Dissanayaka DMS, Jayasena V, Rainey-Smith SR, et al (2024) The role of diet and gut microbiota in Alzheimer\u2019s disease. Nutrients 16:412. https:\/\/doi.org\/10.3390\/nu16030412","DOI":"10.3390\/nu16030412"},{"key":"10927_CR78","doi-asserted-by":"publisher","unstructured":"James KR, Gomes T, Elmentaite R, et al (2020) Distinct microbial and immune niches of the human colon. Nat Immunol 21:343\u2013353. https:\/\/doi.org\/10.1038\/s41590-020-0602-z","DOI":"10.1038\/s41590-020-0602-z"},{"key":"10927_CR79","doi-asserted-by":"publisher","unstructured":"Sun Y, Sommerville NR, Liu JYH, et al (2020) Intra-gastrointestinal amyloid-\u03b21\u201342 oligomers perturb enteric function and induce Alzheimer\u2019s disease pathology. J Physiol 598:4209\u20134223. https:\/\/doi.org\/10.1113\/JP279919","DOI":"10.1113\/JP279919"},{"key":"10927_CR80","doi-asserted-by":"publisher","unstructured":"Nguyen NM, Cho J, Lee C (2023) Gut microbiota and Alzheimer\u2019s disease: how to study and apply their relationship. Int J Mol Sci 24:4047. https:\/\/doi.org\/10.3390\/ijms24044047","DOI":"10.3390\/ijms24044047"},{"key":"10927_CR81","doi-asserted-by":"publisher","unstructured":"Haran JP, Bhattarai SK, Foley SE, et al (2019) Alzheimer\u2019s disease microbiome is associated with dysregulation of the anti-inflammatory p-glycoprotein pathway. mBio 10. https:\/\/doi.org\/10.1128\/mBio.00632-19","DOI":"10.1128\/mBio.00632-19"},{"key":"10927_CR82","doi-asserted-by":"publisher","unstructured":"Kesika P, Suganthy N, Sivamaruthi BS, Chaiyasut C (2021) Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer\u2019s disease. Life Sci 264:118627. https:\/\/doi.org\/10.1016\/j.lfs.2020.118627","DOI":"10.1016\/j.lfs.2020.118627"},{"key":"10927_CR83","doi-asserted-by":"publisher","unstructured":"Prajapati SK, Yadav D, Katiyar S, et al (2025) Postbiotics as mitochondrial modulators in inflammatory bowel disease: mechanistic insights and therapeutic potential. Biomolecules 15:954. https:\/\/doi.org\/10.3390\/biom15070954","DOI":"10.3390\/biom15070954"},{"key":"10927_CR84","doi-asserted-by":"publisher","unstructured":"Yang Z, Luo Y, Yang Z, et al (2026) Mitochondrial dynamics dysfunction and neurodevelopmental disorders: from pathological mechanisms to clinical translation. Neural Regen Res 21:1926\u20131946. https:\/\/doi.org\/10.4103\/NRR.NRR-D-24-01422","DOI":"10.4103\/NRR.NRR-D-24-01422"},{"key":"10927_CR85","doi-asserted-by":"publisher","unstructured":"Wiatrak B, Balon K, Jawie\u0144 P, et al (2022) The role of the microbiota-gut-brain axis in the development of Alzheimer\u2019s disease. Int J Mol Sci 23:4862. https:\/\/doi.org\/10.3390\/ijms23094862","DOI":"10.3390\/ijms23094862"},{"key":"10927_CR86","doi-asserted-by":"publisher","unstructured":"Loh JS, Mak WQ, Tan LKS, et al (2024) Microbiota\u2013gut\u2013brain axis and its therapeutic applications in neurodegenerative diseases. Signal Transduct Target Ther 9:37. https:\/\/doi.org\/10.1038\/s41392-024-01743-1","DOI":"10.1038\/s41392-024-01743-1"},{"key":"10927_CR87","doi-asserted-by":"publisher","unstructured":"Chen L, Xu X, Wu X, et al (2022) A comparison of the composition and functions of the oral and gut microbiotas in Alzheimer\u2019s patients. Front Cell Infect Microbiol 12. https:\/\/doi.org\/10.3389\/fcimb.2022.942460","DOI":"10.3389\/fcimb.2022.942460"},{"key":"10927_CR88","doi-asserted-by":"publisher","unstructured":"Bello-Corral L, Alves-Gomes L, Fern\u00e1ndez-Fern\u00e1ndez JA, et al (2023) Implications of gut and oral microbiota in neuroinflammatory responses in Alzheimer\u2019s disease. Life Sci 333:122132. https:\/\/doi.org\/10.1016\/j.lfs.2023.122132","DOI":"10.1016\/j.lfs.2023.122132"},{"key":"10927_CR89","doi-asserted-by":"publisher","unstructured":"Dioguardi M, Crincoli V, Laino L, et al (2020) The role of periodontitis and periodontal bacteria in the onset and progression of Alzheimer\u2019s disease: a systematic review. J Clin Med 9:495. https:\/\/doi.org\/10.3390\/jcm9020495","DOI":"10.3390\/jcm9020495"},{"key":"10927_CR90","doi-asserted-by":"publisher","unstructured":"Lu J, Zhang S, Huang Y, et al (2022) Periodontitis-related salivary microbiota aggravates Alzheimer\u2019s disease via gut-brain axis crosstalk. Gut Microbes 14. https:\/\/doi.org\/10.1080\/19490976.2022.2126272","DOI":"10.1080\/19490976.2022.2126272"},{"key":"10927_CR91","doi-asserted-by":"publisher","unstructured":"Zang Y, Lai X, Li C, et al (2023) The role of gut microbiota in various neurological and psychiatric disorders\u2014an evidence mapping based on quantified evidence. Mediators Inflamm 2023:1\u201316. https:\/\/doi.org\/10.1155\/2023\/5127157","DOI":"10.1155\/2023\/5127157"},{"key":"10927_CR92","doi-asserted-by":"publisher","unstructured":"Narengaowa, Kong W, Lan F, et al (2021) The oral-gut-brain axis: the influence of microbes in Alzheimer\u2019s disease. Front Cell Neurosci 15. https:\/\/doi.org\/10.3389\/fncel.2021.633735","DOI":"10.3389\/fncel.2021.633735"},{"key":"10927_CR93","doi-asserted-by":"publisher","unstructured":"Kishimoto H, Ohara T, Hata J, et al (2016) The long-term association between physical activity and risk of dementia in the community: the Hisayama study. Eur J Epidemiol 31:267\u2013274. https:\/\/doi.org\/10.1007\/s10654-016-0125-y","DOI":"10.1007\/s10654-016-0125-y"},{"key":"10927_CR94","doi-asserted-by":"publisher","unstructured":"Matyas N, Keser Aschenberger F, Wagner G, et al (2019) Continuing education for the prevention of mild cognitive impairment and Alzheimer\u2019s-type dementia: a systematic review and overview of systematic reviews. BMJ Open 9:e027719. https:\/\/doi.org\/10.1136\/bmjopen-2018-027719","DOI":"10.1136\/bmjopen-2018-027719"},{"key":"10927_CR95","doi-asserted-by":"publisher","unstructured":"Altschul DM, Deary IJ (2020) Playing analog games is associated with reduced declines in cognitive function: a 68-year longitudinal cohort study. J Gerontol B 75:474\u2013482. https:\/\/doi.org\/10.1093\/geronb\/gbz149","DOI":"10.1093\/geronb\/gbz149"},{"key":"10927_CR96","doi-asserted-by":"publisher","unstructured":"Matsunaga S, Kishi T, Nomura I, et al (2018) The efficacy and safety of memantine for the treatment of Alzheimer\u2019s disease. Expert Opin Drug Saf 17:1053\u20131061. https:\/\/doi.org\/10.1080\/14740338.2018.1524870","DOI":"10.1080\/14740338.2018.1524870"},{"key":"10927_CR97","doi-asserted-by":"publisher","unstructured":"Lane CA, Hardy J, Schott JM (2018) Alzheimer\u2019s disease. Eur J Neurol 25:59\u201370. https:\/\/doi.org\/10.1111\/ene.13439","DOI":"10.1111\/ene.13439"},{"key":"10927_CR98","doi-asserted-by":"publisher","unstructured":"Kishi T, Matsunaga S, Oya K, et al (2017) Memantine for Alzheimer\u2019s disease: an updated systematic review and meta-analysis. J Alzheimers Dis 60:401\u2013425. https:\/\/doi.org\/10.3233\/JAD-170424","DOI":"10.3233\/JAD-170424"},{"key":"10927_CR99","unstructured":"Food & Drug Administration (2021) FDA\u2019s decision to approve new treatment for Alzheimer\u2019s disease"},{"key":"10927_CR100","doi-asserted-by":"publisher","unstructured":"Cummings J, Aisen P, Apostolova LG, et al (2021) Aducanumab: appropriate use recommendations. J Prev Alzheimers Dis 8:398\u2013410. https:\/\/doi.org\/10.14283\/jpad.2021.41","DOI":"10.14283\/jpad.2021.41"},{"key":"10927_CR101","doi-asserted-by":"publisher","unstructured":"Akbari E, Asemi Z, Daneshvar Kakhaki R, et al (2016) Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer\u2019s disease: a randomized, double-blind and controlled trial. Front Aging Neurosci 8. https:\/\/doi.org\/10.3389\/fnagi.2016.00256","DOI":"10.3389\/fnagi.2016.00256"},{"key":"10927_CR102","doi-asserted-by":"publisher","unstructured":"Kobayashi Y, Kinoshita T, Matsumoto A, et al (2019) Bifidobacterium breve A1 supplementation improved cognitive decline in older adults with mild cognitive impairment: an open-label, single-arm study. J Prev Alzheimers Dis 6:70\u201375. https:\/\/doi.org\/10.14283\/jpad.2018.32","DOI":"10.14283\/jpad.2018.32"},{"key":"10927_CR103","doi-asserted-by":"publisher","unstructured":"Xiao J, Katsumata N, Bernier F, et al (2020) Probiotic Bifidobacterium breve in improving cognitive functions of older adults with suspected mild cognitive impairment: a randomized, double-blind, placebo-controlled trial. J Alzheimers Dis 77:139\u2013147. https:\/\/doi.org\/10.3233\/JAD-200488","DOI":"10.3233\/JAD-200488"},{"key":"10927_CR104","doi-asserted-by":"publisher","unstructured":"Hsu Y-C, Huang Y-Y, Tsai S-Y, et al (2023) Efficacy of probiotic supplements on brain-derived neurotrophic factor, inflammatory biomarkers, oxidative stress and cognitive function in patients with Alzheimer\u2019s dementia: a 12-week randomized, double-blind active-controlled study. Nutrients 16:16. https:\/\/doi.org\/10.3390\/nu16010016","DOI":"10.3390\/nu16010016"},{"key":"10927_CR105","doi-asserted-by":"publisher","unstructured":"Lee J, Kim H, Kim J, et al (2021) A novel treatment strategy by natural products in NLRP3 inflammasome-mediated neuroinflammation in Alzheimer\u2019s and Parkinson\u2019s disease. Int J Mol Sci 22:1324. https:\/\/doi.org\/10.3390\/ijms22031324","DOI":"10.3390\/ijms22031324"},{"key":"10927_CR106","doi-asserted-by":"publisher","unstructured":"Larroya-Garc\u00eda A, Navas-Carrillo D, Orenes-Pi\u00f1ero E (2019) Impact of gut microbiota on neurological diseases: diet composition and novel treatments. Crit Rev Food Sci Nutr 59:3102\u20133116. https:\/\/doi.org\/10.1080\/10408398.2018.1484340","DOI":"10.1080\/10408398.2018.1484340"},{"key":"10927_CR107","doi-asserted-by":"publisher","unstructured":"Mustafa MA, Vadia N, Varma P, et al (2026) The gut-brain axis in Alzheimer\u2019s disease: exploring microbial influences and therapeutic strategies. Mol Neurobiol 63:151. https:\/\/doi.org\/10.1007\/s12035-025-05474-4","DOI":"10.1007\/s12035-025-05474-4"},{"key":"10927_CR108","doi-asserted-by":"publisher","unstructured":"Vogt NM, Kerby RL, Dill-McFarland KA, et al (2017) Gut microbiome alterations in Alzheimer\u2019s disease. Sci Rep 7:13537. https:\/\/doi.org\/10.1038\/s41598-017-13601-y","DOI":"10.1038\/s41598-017-13601-y"},{"key":"10927_CR109","doi-asserted-by":"publisher","unstructured":"Wu Y, Niu X, Li P, et al (2023) Lactobacillaceae improve cognitive dysfunction via regulating gut microbiota and suppressing A\u03b2 deposits and neuroinflammation in APP\/PS1 mice. Arch Microbiol 205:118. https:\/\/doi.org\/10.1007\/s00203-023-03466-3","DOI":"10.1007\/s00203-023-03466-3"},{"key":"10927_CR110","doi-asserted-by":"publisher","unstructured":"Zhu G, Zhao J, Wang G, Chen W (2023) Bifidobacterium breve HNXY26M4 attenuates cognitive deficits and neuroinflammation by regulating the gut\u2013brain axis in APP\/PS1 mice. J Agric Food Chem 71:4646\u20134655. https:\/\/doi.org\/10.1021\/acs.jafc.3c00652","DOI":"10.1021\/acs.jafc.3c00652"},{"key":"10927_CR111","doi-asserted-by":"publisher","unstructured":"Kwon H, Lee E-H, Park S-Y, et al (2023) Lactobacillus-derived extracellular vesicles counteract A\u03b242-induced abnormal transcriptional changes through the upregulation of MeCP2 and Sirt1 and improve A\u03b2 pathology in Tg-APP\/PS1 mice. Exp Mol Med 55:2067\u20132082. https:\/\/doi.org\/10.1038\/s12276-023-01084-z","DOI":"10.1038\/s12276-023-01084-z"},{"key":"10927_CR112","doi-asserted-by":"publisher","unstructured":"Lee H-G, Wheeler MA, Quintana FJ (2022) Function and therapeutic value of astrocytes in neurological diseases. Nat Rev Drug Discov 21:339\u2013358. https:\/\/doi.org\/10.1038\/s41573-022-00390-x","DOI":"10.1038\/s41573-022-00390-x"},{"key":"10927_CR113","doi-asserted-by":"publisher","unstructured":"Yang X, Yu D, Xue L, et al (2020) Probiotics modulate the microbiota\u2013gut\u2013brain axis and improve memory deficits in aged SAMP8 mice. Acta Pharm Sin B 10:475\u2013487. https:\/\/doi.org\/10.1016\/j.apsb.2019.07.001","DOI":"10.1016\/j.apsb.2019.07.001"},{"key":"10927_CR114","doi-asserted-by":"publisher","unstructured":"Kim YJ, Mun B-R, Choi KY, Choi W-S (2024) Oral administration of probiotic bacteria alleviates tau phosphorylation, A\u03b2 accumulation, microglia activation, and memory loss in 5xFAD mice. Brain Sci 14:208. https:\/\/doi.org\/10.3390\/brainsci14030208","DOI":"10.3390\/brainsci14030208"},{"key":"10927_CR115","doi-asserted-by":"publisher","unstructured":"Bonfili L, Cecarini V, Cuccioloni M, et al (2018) SLAB51 probiotic formulation activates SIRT1 pathway promoting antioxidant and neuroprotective effects in an AD mouse model. Mol Neurobiol 55:7987\u20138000. https:\/\/doi.org\/10.1007\/s12035-018-0973-4","DOI":"10.1007\/s12035-018-0973-4"},{"key":"10927_CR116","doi-asserted-by":"publisher","unstructured":"Abdelhamid M, Zhou C, Jung C-G, Michikawa M (2022) Probiotic Bifidobacterium breve MCC1274 mitigates Alzheimer\u2019s disease-related pathologies in wild-type mice. Nutrients 14:2543. https:\/\/doi.org\/10.3390\/nu14122543","DOI":"10.3390\/nu14122543"},{"key":"10927_CR117","doi-asserted-by":"publisher","unstructured":"Abdelhamid M, Jung C-G, Zhou C, et al (2024) Potential therapeutic effects of Bifidobacterium breve MCC1274 on Alzheimer\u2019s disease pathologies in AppNL-G-F mice. Nutrients 16:538. https:\/\/doi.org\/10.3390\/nu16040538","DOI":"10.3390\/nu16040538"},{"key":"10927_CR118","doi-asserted-by":"publisher","unstructured":"Abdelhamid M, Counts SE, Zhou C, et al (2025) Protective effects of Bifidobacterium breve MCC1274 as a novel therapy for Alzheimer\u2019s disease. Nutrients 17:558. https:\/\/doi.org\/10.3390\/nu17030558","DOI":"10.3390\/nu17030558"},{"key":"10927_CR119","doi-asserted-by":"publisher","unstructured":"Ohno K, Abdelhamid M, Zhou C, et al (2022) Bifidobacterium breve MCC1274 supplementation increased the plasma levels of metabolites with potential anti-oxidative activity in APP knock-in mice. J Alzheimers Dis 89:1413\u20131425. https:\/\/doi.org\/10.3233\/JAD-220479","DOI":"10.3233\/JAD-220479"},{"key":"10927_CR120","doi-asserted-by":"publisher","unstructured":"Sushma G, Vaidya B, Sharma S, et al (2023) Bifidobacterium breve Bif11 supplementation improves depression-related neurobehavioural and neuroinflammatory changes in the mouse. Neuropharmacology 229:109480. https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109480","DOI":"10.1016\/j.neuropharm.2023.109480"},{"key":"10927_CR121","doi-asserted-by":"publisher","unstructured":"Kim H, Shin J, Kim S, et al (2022) Bifidobacterium bifidum BGN4 and Bifidobacterium longum BORI promotes neuronal rejuvenation in aged mice. Biochem Biophys Res Commun 603:41\u201348. https:\/\/doi.org\/10.1016\/j.bbrc.2022.03.024","DOI":"10.1016\/j.bbrc.2022.03.024"},{"key":"10927_CR122","doi-asserted-by":"publisher","unstructured":"Kim H, Kim S, Park S, et al (2021) Administration of Bifidobacterium bifidum BGN4 and Bifidobacterium longum BORI improves cognitive and memory function in the mouse model of Alzheimer\u2019s disease. Front Aging Neurosci 13. https:\/\/doi.org\/10.3389\/fnagi.2021.709091","DOI":"10.3389\/fnagi.2021.709091"},{"key":"10927_CR123","doi-asserted-by":"publisher","unstructured":"Abdelhamid M, Zhou C, Ohno K, et al (2022) Probiotic Bifidobacterium breve prevents memory impairment through the reduction of both amyloid-\u03b2 production and microglia activation in APP knock-in mouse. J Alzheimers Dis 85:1555\u20131571. https:\/\/doi.org\/10.3233\/JAD-215025","DOI":"10.3233\/JAD-215025"},{"key":"10927_CR124","doi-asserted-by":"publisher","unstructured":"Asaoka D, Xiao J, Takeda T, et al (2022) Effect of probiotic Bifidobacterium breve in improving cognitive function and preventing brain atrophy in older patients with suspected mild cognitive impairment: results of a 24-week randomized, double-blind, placebo-controlled trial. J Alzheimers Dis 88:75\u201395. https:\/\/doi.org\/10.3233\/JAD-220148","DOI":"10.3233\/JAD-220148"},{"key":"10927_CR125","doi-asserted-by":"publisher","unstructured":"Shi S, Zhang Q, Sang Y, et al (2022) Probiotic Bifidobacterium longum BB68S improves cognitive functions in healthy older adults: a randomized, double-blind, placebo-controlled trial. Nutrients 15:51. https:\/\/doi.org\/10.3390\/nu15010051","DOI":"10.3390\/nu15010051"},{"key":"10927_CR126","doi-asserted-by":"publisher","unstructured":"Akhgarjand C, Vahabi Z, Shab-Bidar S, et al (2024) The effects of probiotic supplements on oxidative stress and inflammation in subjects with mild and moderate Alzheimer\u2019s disease: a randomized, double-blind, placebo-controlled study. Inflammopharmacology 32:1413\u20131420. https:\/\/doi.org\/10.1007\/s10787-023-01427-2","DOI":"10.1007\/s10787-023-01427-2"},{"key":"10927_CR127","doi-asserted-by":"publisher","unstructured":"Jouni N, Akhgarjand C, Vahabi Z, et al (2025) Strain specific effects of probiotic supplementation on serum amino acid profiles in Alzheimer\u2019s disease: a randomized, double blind, placebo controlled trial. Sci Rep 15:29924. https:\/\/doi.org\/10.1038\/s41598-025-15355-4","DOI":"10.1038\/s41598-025-15355-4"},{"key":"10927_CR128","doi-asserted-by":"publisher","unstructured":"Eastwood J, van Hemert S, Stolaki M, et al (2025) Exploring the acute and chronic effects of a multistrain probiotic supplement on cognitive function and mood in healthy older adults: a randomized controlled trial. Am J Clin Nutr 121:1268\u20131280. https:\/\/doi.org\/10.1016\/j.ajcnut.2025.04.002","DOI":"10.1016\/j.ajcnut.2025.04.002"},{"key":"10927_CR129","doi-asserted-by":"publisher","unstructured":"Kobayashi Y, Kuhara T, Oki M, Xiao J-Z (2019) Effects of Bifidobacterium breve A1 on the cognitive function of older adults with memory complaints: a randomised, double-blind, placebo-controlled trial. Benef Microbes 10:511\u2013520. https:\/\/doi.org\/10.3920\/BM2018.0170","DOI":"10.3920\/BM2018.0170"},{"key":"10927_CR130","doi-asserted-by":"publisher","unstructured":"Hwang Y-H, Park S, Paik J-W, et al (2019) Efficacy and safety of Lactobacillus plantarum C29-fermented soybean (DW2009) in individuals with mild cognitive impairment: a 12-week, multi-center, randomized, double-blind, placebo-controlled clinical trial. Nutrients 11:305. https:\/\/doi.org\/10.3390\/nu11020305","DOI":"10.3390\/nu11020305"},{"key":"10927_CR131","doi-asserted-by":"publisher","unstructured":"Sakurai K, Toshimitsu T, Okada E, et al (2022) Effects of Lactiplantibacillus plantarum OLL2712 on memory function in older adults with declining memory: a randomized placebo-controlled trial. Nutrients 14:4300. https:\/\/doi.org\/10.3390\/nu14204300","DOI":"10.3390\/nu14204300"},{"key":"10927_CR132","doi-asserted-by":"publisher","unstructured":"Kim C-S, Jung S, Hwang G-S, Shin D-M (2023) Gut microbiota indole-3-propionic acid mediates neuroprotective effect of probiotic consumption in healthy elderly: a randomized, double-blind, placebo-controlled, multicenter trial and in vitro study. Clin Nutr 42:1025\u20131033. https:\/\/doi.org\/10.1016\/j.clnu.2023.04.001","DOI":"10.1016\/j.clnu.2023.04.001"},{"key":"10927_CR133","doi-asserted-by":"publisher","unstructured":"Jung S-J, Cho K, Jung E-S, et al (2025) Augmenting cognitive function in the elderly with mild cognitive impairment using probiotic Lacticaseibacillus rhamnosus CBT-LR5: a 12-week randomized, double-blind, parallel-group non-comparative study. Nutrients 17:691. https:\/\/doi.org\/10.3390\/nu17040691","DOI":"10.3390\/nu17040691"},{"key":"10927_CR134","doi-asserted-by":"publisher","unstructured":"Kim C-S, Cha J, Sim M, et al (2021) Probiotic supplementation improves cognitive function and mood with changes in gut microbiota in community-dwelling older adults: a randomized, double-blind, placebo-controlled, multicenter trial. J Gerontol A 76:32\u201340. https:\/\/doi.org\/10.1093\/gerona\/glaa090","DOI":"10.1093\/gerona\/glaa090"},{"key":"10927_CR135","doi-asserted-by":"publisher","unstructured":"Fei Y, Wang R, Lu J, et al (2023) Probiotic intervention benefits multiple neural behaviors in older adults with mild cognitive impairment. Geriatr Nurs 51:167\u2013175. https:\/\/doi.org\/10.1016\/j.gerinurse.2023.03.006","DOI":"10.1016\/j.gerinurse.2023.03.006"},{"key":"10927_CR136","doi-asserted-by":"publisher","unstructured":"Pavithra R, Kanimozhi NV, Sonali L, et al (2025) Unveiling role of gut microbiota in Alzheimer\u2019s disease: mechanisms, challenges and future perspectives. Curr Alzheimer Res 22. https:\/\/doi.org\/10.2174\/0115672050403066250904112611","DOI":"10.2174\/0115672050403066250904112611"},{"key":"10927_CR137","doi-asserted-by":"publisher","unstructured":"Sarkar SK, Gubert C, Hannan AJ (2025) The microbiota-inflammasome-brain axis as a pathogenic mediator of neurodegenerative disorders. Neurosci Biobehav Rev 176:106276. https:\/\/doi.org\/10.1016\/j.neubiorev.2025.106276","DOI":"10.1016\/j.neubiorev.2025.106276"},{"key":"10927_CR138","doi-asserted-by":"publisher","unstructured":"Liu Y, Tang T, Cai H, Liu Z (2025) Bidirectional communication between the gut microbiota and the central nervous system. Neural Regen Res. https:\/\/doi.org\/10.4103\/NRR.NRR-D-25-00434","DOI":"10.4103\/NRR.NRR-D-25-00434"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-026-10927-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-026-10927-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-026-10927-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:19:41Z","timestamp":1787725181000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-026-10927-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":138,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10927"],"URL":"https:\/\/doi.org\/10.1007\/s12602-026-10927-w","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"15 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}